(Reuters)—The U.S. Food and Drug Administration needs Corbus Pharmaceuticals to show positive data from only one late-stage study on its experimental treatment for scleroderma to support a marketing application, the company said. Corbus said on Wednesday it expects to start the study on 270 patients in the fourth quarter and that it was in talks…
Articles by Natasha Yetman
Trump Nominee to Lead FDA Probed on Ties to Pharmacy Industry
(Reuters)—President Donald Trump’s nominee to lead the U.S. Food and Drug Administration, Dr. Scott Gottlieb, was questioned about his ties to the pharmaceutical industry by Democrats on a key Senate committee on Wednesday ahead of a vote on whether to advance his nomination for a vote by the full Senate. Gottlieb, 44, is a former…
Recommendations for Sjögren’s Syndrome: How to Address Biologics & Musculoskeletal Pain
The clinical practice guidelines for managing Sjögren’s syndrome, developed by the Sjögren’s Syndrome Foundation with the ACR, were designed to improve quality and consistency of care. In total, 19 recommendations were agreed on, which include managing the rheumatic and systemic aspects of the disease. Recommendations include a decision tree for the use of DMARDs for inflammatory musculoskeletal pain, use of self-care measures and exercise to reduce fatigue, and the use of rituximab in selected clinical settings for oral and ocular dryness…
Would Legalizing Medical Marijuana Help Curb the Opioid Epidemic?
(Reuters Health)—In states that legalized medical marijuana, U.S. hospitals failed to see a predicted influx of pot smokers, but in an unexpected twist, they treated far fewer opioid users, a new study shows. Hospitalization rates for opioid painkiller dependence and abuse dropped on average 23% in states after marijuana was permitted for medicinal purposes, the…
New Position Paper Aims to Reduce Administrative Tasks in Healthcare
NEW YORK (Reuters Health)—A new position paper from the American College of Physicians (ACP) aims to reduce administrative tasks in health care. Reducing these tasks has been an important long-term objective of ACP, which developed the Patients before Paperwork initiative in 2015 as part of this effort. In a publication online on March 27 in…
Dermatology Consults May Cut Hospital Stays, Readmissions
NEW YORK (Reuters Health)—Inpatient dermatology consultations were associated with shorter hospital stays and reduced readmissions in a U.S. medical center and may do the same elsewhere, researchers in Ohio suggest. “A few decades ago, patients with severe psoriasis, drug reactions, blistering diseases and even severe eczema would be admitted to the hospital under close dermatology…
Republicans Pull Healthcare Legislation
WASHINGTON (Reuters)—President Donald Trump suffered a stunning political setback on Friday in a Congress controlled by his own party when Republican leaders pulled legislation to overhaul the U.S. healthcare system, a major 2016 election campaign promise of the president and his allies. Republican leaders of the House of Representatives pulled the legislation due to a…
When Starting Biologics for RA, Disease Severity Predicts Likelihood of Remission
NEW YORK (Reuters Health)—After starting biologic therapy for rheumatoid arthritis (RA), patients with higher disease activity at baseline achieved greater improvements in measures of disease activity than those with lower levels of disease, but they were less likely to achieve remission or even low disease activity, according to a new real world analysis of registry data….
Republicans Revamp U.S. Health Bill, Boost Benefits to Older Americans
WASHINGTON (Reuters)—U.S. House Republicans are working on changes to their healthcare overhaul bill to provide more generous tax credits for older Americans and add a work requirement for the Medicaid program for the poor, House Speaker Paul Ryan (R-Wis.) said on Sunday. Ryan said Republican leaders still planned to bring the healthcare bill to a…
Hospitals Have Lower Death Rates During Surprise Inspections
(Reuters Health)—Patients may be less likely to die in U.S. hospitals during weeks when accreditation inspectors show up unannounced than during other times of the year, a recent U.S. study suggests. Researchers examined mortality data for 1,984 hospitals nationwide from 2008 to 2012. During surprise inspections, 7.03% of patients died within 30 days of being…
- « Previous Page
- 1
- …
- 48
- 49
- 50
- 51
- 52
- …
- 98
- Next Page »